Evidence map›Paper›PMID 39920525›Full record

ArticleBehavior genetics2025

Alcohol use in Early Midlife: Findings from the Age 37 Follow-Up Assessment of the FinnTwin12 Cohort.

Megan E Cooke, Erin Lumpe, Mallory Stephenson, Mia Urjansson, Fazil Aliev, Teemu Palviainen, Sarah J Brislin, Maarit Piirtola, Jill Rabinowitz, Antti Latvala and 9 more

Abstract readTwin Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Behavior genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Megan E Cooke *Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, USA.
Erin Lumpe *Department of Psychology, Rutgers University, New Brunswick, USA.
Mallory Stephenson *Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, USA.
Mia UrjanssonInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Fazil AlievDepartment of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, USA.
Teemu PalviainenInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Sarah J BrislinDepartment of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, USA.
Maarit PiirtolaInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Jill RabinowitzDepartment of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, USA.
Antti LatvalaInstitute of Criminology and Legal Policy, University of Helsinki, Helsinki, Finland.
Peter B BarrDepartment of Psychiatry and Behavioral Sciences, SUNY Downstate Health Sciences University, Brooklyn, USA.
Eero VuoksimaaInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
Hermine H M MaesVirginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, USA.
Richard VikenDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, USA.
Richard J RoseDepartment of Psychological and Brain Sciences, Indiana University, Bloomington, USA.
Jaakko Kaprio *Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland. jaakko.kaprio@helsinki.fi.
Danielle M Dick *Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, USA. danielle.m.dick@rutgers.edu.
Sari Aaltonen *Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland. sari.s.aaltonen@helsinki.fi.
Jessica E Salvatore *Department of Psychiatry, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, USA. jessica.salvatore@rutgers.edu.

Funding

NRSA TrainingTL1TR003019 · NCATS · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI SCOTTO, KATHLEEN W. · 2019 to 2023
$1.9M
Neural, genetic, and environmental indicators of treatment outcomes for adolescent substance useK23DA058808 · NIDA · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Sarah Brislin · 2024 to 2026
$542k
Academy of Finland 265240, 263278, 308248, 312073 and 352792NCATS NIH HHS TL1 TR003019NCATS NIH HHS TL1TR003019NIDA NIH HHS K23 DA058808
6 · The paper itself

Abstract

This paper provides an overview of the most recent assessment, collected in early midlife, of the FinnTwin12 cohort, a population-based study of Finnish twins born in 1983-1987. The twins were invited to complete an online survey assessing a range of variables, including physical and mental health, alcohol use and problems, other substance use, and early midlife environments (e.g., parenthood). In total, 2,085 individuals (~ 40% of the original sample) completed the survey (551 complete twin pairs, 58.7% female, 37.3% monozygotic, M

Indexed as

Alcohol DrinkingAdultAlcoholismCohort StudiesFemaleFinlandFollow-Up StudiesHumansMaleSurveys and QuestionnairesTwinsTwins, DizygoticTwins, MonozygoticAlcoholCohort studyEarly MidlifeLongitudinal twin-family studySex differencesTwins

Identifiers

PMID39920525
PMCPMC11882652

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.